The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders
Abstract
Cognitive dysfunction is a prominent feature of psychiatric disorders. Studies have shown that systemic low-grade inflammation is crucial in the development of cognitive deficits across psychiatric disorders. The aim of this study was to further examine the role of inflammation and inflammatory mediators in cognitive function in psychiatric disorders. This study included 364 inpatients (53% females) with International Classification of Diseases (ICD)-10 F3 (affective disorders) and F4 (neurotic, stress-related, and somatoform disorders) diagnoses. The mean age was 52 years (22 to 69 years) and the median body mass index was 27.6. Cognitive function was assessed with the Color–Word Interference Test after Stroop and the Trail-Making Test A/B. Multiple linear regression models were calculated to assess the predictive value of C-reactive protein and the kynurenine/tryptophan ratio on cognitive function controlling for age, sex, education, premorbid verbal intelligence quotient, illness duration, depressive symptoms, and obesity-related parameters (e.g., body mass index, high-density lipoprotein). Our data confirm that in patients with psychiatric disorders, C-reactive protein serum concentration is a relevant and important predictor of Trail-Making Test B performance, measuring cognitive flexibility. The effect size of this association did not change much after adding clinical and metabolic variables into the regression model. The kynurenine/tryptophan ratio was not related to cognitive test scores. The involvement of C-reactive protein as a peripheral inflammatory marker in cognitive flexibility and psychomotor processing speed in psychiatric illness can be concluded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is also reported that an activated inflammatory system is associated with abnormal hedonic and cognitive function in adults with depression (5–7).”
From The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis (2022) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cognitive impairment in depression: a systematic review and meta-analysis
Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014) · Psychological Medicine · doi:10.1017/s0033291713002535 · Cited by 2,161
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683 · cited 1×
“Pro-inflammatory cytokines seem to play an important role in the clinical course of psychiatric disorders, and it is suggested that inflammatory markers can be associated with the severity and quantity of depressive symptoms [12,14].”
BackgroundSnyder, H. R. (2013) · Psychological Bulletin · doi:10.1037/a0028727 · Cited by 1,667
Brain foods: The effects of nutrients on brain function.
Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372
The metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025 · cited 1×
“found that elevated serum levels of hsCRP were associated with cognitive decline in individuals with metabolic syndrome [41].”
BackgroundCRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.004 · Cited by 972 · cited 1×
“In a meta-analysis, pro-inflammatory cytokines were revealed to contribute to the causal mechanism in mental disorders [15].”
BackgroundA meta-analysis of depression severity and cognitive function
McDermott, L. M., & Ebmeier, K. P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.022 · Cited by 956
Neurocognitive deficits and disability in major depressive disorder
Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.11.011 · Cited by 484
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402 · cited 1×
“Because of methodological heterogeneity between studies, insufficient standardization, and a lack of control for confounds, more research with large samples controlling for relevant clinical and metabolic confounders is needed [43,49].”
Background
Research works printed but not linked: 46
- Arts, 2008, Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives, Psychol Med., 38, 771, 10.1017/S0033291707001675 · DOI · Paper page
- Lee, 2012, A meta-analysis of cognitive deficits in first-episode major depressive disorder, J. Affect. Disord., 140, 113, 10.1016/j.jad.2011.10.023 · DOI · Paper page
- Robinson, 2006, A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder, J. Affect. Disord., 93, 105, 10.1016/j.jad.2006.02.016 · DOI · Paper page
- Millan, 2012, Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy, Nat. Rev. Drug Discov., 11, 141, 10.1038/nrd3628 · DOI · Paper page
- Alvarez, 2006, Executive function and the frontal lobes: A meta-analytic review, Neuropsychol. Rev., 16, 17, 10.1007/s11065-006-9002-x · DOI · Paper page
- Martino, 2014, Longitudinal course of cognitive deficits in bipolar disorder: A meta-analytic study, J. Affect. Disord., 164, 130, 10.1016/j.jad.2014.04.028 · DOI
- Allison, 2014, The common inflammatory etiology of depression and cognitive impairment: A therapeutic target, J. Neuroinflammation, 11, 1, 10.1186/s12974-014-0151-1 · DOI · Paper page
- Fourrier, 2019, Neuroinflammation and cognition across psychiatric conditions, CNS Spectr., 24, 4, 10.1017/S1092852918001499 · DOI
- Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis, Psychosom Med., 71, 171, 10.1097/PSY.0b013e3181907c1b · DOI · Paper page
- Dixon, 2010, The effect of obesity on health outcomes, Mol Cell Endocrinol, 316, 104, 10.1016/j.mce.2009.07.008 · DOI · Paper page
- Penninx, 2001, Depression and cardiac mortality: Results from a community-based longitudinal study, Arch. Gen. Psychiatry, 58, 221, 10.1001/archpsyc.58.3.221 · DOI · Paper page
- Soczynska, 2011, Mood disorders and obesity: Understanding inflammation as a pathophysiological nexus, Neuromol. Med., 13, 93, 10.1007/s12017-010-8140-8 · DOI · Paper page
- Choi, 2013, Obesity and C-reactive protein in various populations: A systematic review and meta-analysis, Obes. Rev., 14, 232, 10.1111/obr.12003 · DOI · Paper page
- Santos, 2005, Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome, Int. J. Obes., 29, 1452, 10.1038/sj.ijo.0803035 · DOI · Paper page
- Dowlati, 2010, A meta-analysis of cytokines in major depression, Biol Psychiatry, 67, 446, 10.1016/j.biopsych.2009.09.033 · DOI · Paper page
- Teunissen, 2003, Inflammation markers in relation to cognition in a healthy aging population, J. Neuroimmunol., 134, 142, 10.1016/S0165-5728(02)00398-3 · DOI · Paper page
- Karalis, 2009, Mechanisms of obesity and related pathology: Linking immune responses to metabolic stress, Febs J., 276, 5747, 10.1111/j.1742-4658.2009.07304.x · DOI · Paper page
- Spyridaki, 2016, Obesity, inflammation and cognition, Curr. Opin. Behav. Sci., 9, 169, 10.1016/j.cobeha.2016.05.004 · DOI
- Furukawa, 2017, Increased oxidative stress in obesity and its impact on metabolic syndrome, J. Clin. Investig., 114, 1752, 10.1172/JCI21625 · DOI · Paper page
- Fagundo, A.B., de la Torre, R., Jiménez-Murcia, S., Agüera, Z., Granero, R., Tárrega, S., Botella, C., Baños, R., Fernández-Real, J.M., and Rodríguez, R. (2012). Executive functions profile in extreme eating/weight conditions: From anorexia nervosa to obesity. PLoS ONE, 7. · DOI · Paper page
- Fergenbaum, 2009, Obesity and lowered cognitive performance in a Canadian First Nations population, Obesity, 17, 1957, 10.1038/oby.2009.161 · DOI
- Hall, 2008, Executive function moderates the intention-behavior link for physical activity and dietary behavior, Psychol. Health, 23, 309, 10.1080/14768320701212099 · DOI · Paper page
- Riggs, 2010, Executive cognitive function as a correlate and predictor of child food intake and physical activity, Child. Neuropsychol., 16, 279, 10.1080/09297041003601488 · DOI
- Mangge, 2014, Disturbed tryptophan metabolism in cardiovascular disease, Curr Med. Chem, 21, 1931, 10.2174/0929867321666140304105526 · DOI
- Reininghaus, 2014, Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: A preliminary report, Bipolar Disord., 16, 432, 10.1111/bdi.12166 · DOI
- Birner, A., Platzer, M., Bengesser, S.A., Dalkner, N., Fellendorf, F.T., Queissner, R., Pilz, R., Rauch, P., Maget, A., and Hamm, C. (2017). Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder. PLoS ONE, 12. · DOI
- Kuo, 2005, Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-analysis, Lancet Neurol., 4, 371, 10.1016/S1474-4422(05)70099-5 · DOI · Paper page
- Misiak, 2017, Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review, Schizophr. Res., 192, 16, 10.1016/j.schres.2017.04.015 · DOI · Paper page
- Jonsdottir, 2017, Associations between systemic pro-inflammatory markers, cognitive function and cognitive complaints in a population-based sample of working adults, J. Psychosom. Res., 96, 49, 10.1016/j.jpsychores.2017.03.010 · DOI
- Gimeno, 2009, Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study, Psychol. Med., 39, 413, 10.1017/S0033291708003723 · DOI · Paper page
- Dickerson, 2014, A longitudinal study of cognitive functioning in schizophrenia: Clinical and biological predictors, Schizophr Res., 156, 248, 10.1016/j.schres.2014.04.019 · DOI
- Chang, 2012, Treatment response and cognitive impairment in major depression: Association with C-reactive protein, Brain Behav. Immun., 26, 90, 10.1016/j.bbi.2011.07.239 · DOI · Paper page
- Krogh, 2014, The association between depressive symptoms, cognitive function, and inflammation in major depression, Brain Behav. Immun., 35, 70, 10.1016/j.bbi.2013.08.014 · DOI · Paper page
- Platzer, 2017, Tryptophan breakdown and cognition in bipolar disorder, Psychoneuroendocrinology, 81, 144, 10.1016/j.psyneuen.2017.04.015 · DOI
- Forrest, 2011, Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery, J. Neurochem., 119, 136, 10.1111/j.1471-4159.2011.07414.x · DOI
- Lehrl, 1995, Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence, Acta Neurol. Scand., 91, 335, 10.1111/j.1600-0404.1995.tb07018.x · DOI · Paper page
- Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Guy, W. (1976). Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology, Revised. · DOI · Paper page
- Widner, 1997, Simultaneous measurement of serum tryptophan and kynurenine by HPLC, Clin. Chem., 43, 2424, 10.1093/clinchem/43.12.2424 · DOI · Paper page
- Sumitani, 2007, Activation of the prefrontal cortex during the Trail-Making Test detected with multichannel near-infrared spectroscopy, Psychiatry Clin. Neurosci., 61, 616, 10.1111/j.1440-1819.2007.01727.x · DOI
- Kortte, 2002, The trail making test, part B: Cognitive flexibility or ability to maintain set?, Appl. Neuropsychol., 9, 106, 10.1207/S15324826AN0902_5 · DOI · Paper page
- Demakis, 2004, Frontal lobe damage and tests of executive processing: A meta-analysis of the category test, stroop test, and trail-making test, J. Clin. Exp. Neuropsychol., 26, 441, 10.1080/13803390490510149 · DOI · Paper page
- Fabricatore, 2011, Intentional weight loss and changes in symptoms of depression: A systematic review and meta-analysis, Int. J. Obes., 35, 1363, 10.1038/ijo.2011.2 · DOI · Paper page
- Siervo, 2011, Intentional weight loss in overweight and obese individuals and cognitive function: A systematic review and meta-analysis, Obes. Rev., 12, 968, 10.1111/j.1467-789X.2011.00903.x · DOI · Paper page
- Sutliffe, 2015, C-reactive protein response to a vegan lifestyle intervention, Complementary Ther. Med., 23, 32, 10.1016/j.ctim.2014.11.001 · DOI
- Lee, 2013, Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients, Psychol. Med., 43, 1161, 10.1017/S0033291712002127 · DOI
Cited by
Ma, H., Xu, J., Li, R., McIntyre, R. S., Teopiz, K. M., Cao, B., & Yang, F. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.844176 · Cited by 22
Self-citation
Metadata
- Authors
- Dalkner, N., Reininghaus, E., Schwalsberger, K., Rieger, A., Hamm, C., Pilz, R., Lenger, M., Queissner, R., Falzberger, V. S., Platzer, M., Fellendorf, F. T., Birner, A., Bengesser, S. A., Weiss, E. M., McIntyre, R. S., Mangge, H., & Reininghaus, B.
- Affiliations
- Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, 8036 Graz, Austria
- Therapiezentrum Justuspark, 4540 Bad Hall, Austria
- Institute of Psychology, University of Innsbruck, 6020 Innsbruck, Austria
- Department of Psychiatry and Pharmacology, University of Toronto, Toronto, ON 399, Canada
- Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University, 8036 Graz, Austria
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-10-02
- Volume
- 12
- Issue
- 10
- Pages
- 3019
- ISSN
- 2072-6643
- Cited by
- 10
- References
- 19
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders. https://app.cochat.ai/papers/10.3390/nu12103019
- The paper
- Dalkner, N., Reininghaus, E., Schwalsberger, K., Rieger, A., Hamm, C., Pilz, R., Lenger, M., Queissner, R., Falzberger, V. S., Platzer, M., Fellendorf, F. T., Birner, A., Bengesser, S. A., Weiss, E. M., McIntyre, R. S., Mangge, H., & Reininghaus, B. (2020). C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders. Nutrients. https://doi.org/10.3390/nu12103019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.